Aardvark Therapeutics, Inc. Common Stock (AARD) earnings · $284.4M cap
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
This AARD earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
When the next AARD 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full AARD research stays on the stock page; the tape stays on the quote page.
Not investment advice.